CVE-2025-61885: Oracle Life Sciences InForm · Information Exposure
Affects Oracle Life Sciences InFormSource CVE Database V5
Not known to be exploited · CVSS 4.3 Medium.
Data as of 25 Oct 2026, 19:02 UTC
- EPSS
- 0.2% chance of exploitation in 30 days – higher than 14% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:NExploitation evidence
Disclosed: evidence found.
CVE published 21 Oct 2025
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 2026-10-25.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Oracle Corporation Oracle Life Sciences InForm | Affected
| Fixed in– |
AI-suggested
1. Restrict network access to Oracle Life Sciences InForm web server to trusted internal networks and VPNs only, minimizing exposure to untrusted networks. 2. Implement strict access controls and monitor user privileges to ensure only authorized low-privilege accounts exist. 3. Deploy web application firewalls (WAF) with rules tailored to detect and block suspicious HTTP requests targeting the InForm application. 4. Conduct regular audits and monitoring of HTTP traffic logs for unusual access patterns or data exfiltration attempts. 5. Engage with Oracle support to obtain patches or security updates as soon as they become available and apply them promptly. 6. If patching is not immediately possible, consider isolating the affected system or using network segmentation to limit potential attacker movement. 7. Educate security teams about this specific vulnerability to enhance detection and response capabilities. 8. Review and enhance data encryption and masking within the application to reduce the impact of unauthorized read access.
Description
Vulnerability in the Oracle Life Sciences InForm product of Oracle Health Sciences Applications (component: Web Server). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences InForm accessible data. CVSS 3.1 Base Score 4.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N).